LETRASAN Deva

£106.00

LETRASAN Deva is a pharmaceutical-grade letrozole preparation formulated for advanced in-vitro research protocols investigating aromatase enzyme inhibition and estrogen biosynthesis modulation.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
LETRASAN Deva
LETRASAN Deva
£106.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

LETRASAN Deva: Compound Profile

LETRASAN Deva is a pharmaceutical-grade letrozole preparation engineered for laboratory research into aromatase enzyme inhibition mechanisms. Letrozole is a potent non-steroidal aromatase inhibitor that selectively binds to the CYP19A1 enzyme complex, blocking the conversion of androgens to estrogens in research models. This compound represents a critical tool for investigating estrogen biosynthesis pathways and hormonal regulation systems in controlled laboratory environments. Researchers at Stroid UK Shop rely on LETRASAN Deva for its consistent formulation and pharmaceutical-grade purity standards.

Laboratory Applications

LETRASAN Deva enables comprehensive research into aromatase enzyme function and estrogen-dependent cellular processes. Scientists investigate its mechanism of competitive inhibition at the aromatase active site, examining how letrozole disrupts the cytochrome P450-mediated conversion of androstenedione and testosterone to estrone and estradiol. Research protocols examine its effects on hormone-sensitive tissue models and its role in disrupting estrogen receptor signalling cascades. The compound’s high selectivity for aromatase over other cytochrome P450 enzymes makes it valuable for studies requiring precise estrogen suppression without off-target effects. Researchers studying aromatase inhibitors often compare letrozole’s potency against other inhibitor classes. Studies frequently examine its applications alongside SARMs research compounds and peptide investigations in comprehensive hormonal modulation protocols.

Technical Specifications

LETRASAN Deva Research Specifications
Active Compound Letrozole
CAS Registry 112809-51-5
Molecular Formula C₁₇H₁₁N₅
Molecular Weight 285.30 g/mol
Formulation Pharmaceutical preparation
Storage Requirements Room temperature, dry conditions, light protection
Research Applications Aromatase inhibition, estrogen pathway studies

Research Compliance

LETRASAN Deva is supplied exclusively for in-vitro laboratory research purposes and is not intended for human consumption, therapeutic applications, or diagnostic procedures. Researchers must ensure proper laboratory protocols, appropriate safety measures, and compliance with institutional research guidelines when handling this compound. This product is restricted to qualified research facilities and licensed investigators conducting legitimate scientific studies into aromatase enzyme mechanisms and hormonal biochemistry research applications.

Related